Press release under regulation 30 of the SEBI(LODR) Regulations, 2015.
Awaiting price reaction for this filing.
AVI Polymers Ltd reported a dramatic turnaround in FY26 with revenue surging to ₹312.11 crore from just ₹30.06 crore in FY25, representing a 10x increase. Net profit jumped 24.9x to ₹20.33 crore, while net worth expanded 20.5x to ₹115.99 crore. The company successfully completed a fully subscribed ₹89.99 crore rights issue in January-March 2026. PBT margin stood at 8.88% and PAT margin at 6.51%. Critically, despite share capital expanding 23-fold due to the rights issue, EPS grew from ₹2.00 to ₹32.16, showing underlying business growth outpaced dilution. The company also launched two AI subsidiaries — KrishiBuddy (live agritech platform) and AVIHealth AI (launching by May 3, 2026) — positioning itself in India's AgriTech and HealthTech sectors.
The stock could see positive sentiment given the exceptional turnaround metrics, strong cash position of ₹16.60 crore, and virtually unlevered balance sheet. However, the massive equity dilution from the rights issue and the high-risk pivot into unproven AI technology businesses warrant caution. Dividend has been deferred to fund digital expansion.